Literature DB >> 16718277

Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4 and 10 ng/ml.

O Kaygisiz1, O Uğurlu, M Koşan, G Inal, B Oztürk, M Cetinkaya.   

Abstract

We investigated the effect of prostatic inflammation on prostate-specific antigen (PSA) and per cent-free PSA levels changing after antibacterial therapy. We evaluated 48 patients whose PSA levels were between 4 and 10 ng/ml, without any suspicious findings on digital rectal examination, with no infection findings in urine analysis. Prostatic inflammation was assessed with prostatic massage. All the patients were given antibiotic therapy for 3 weeks. Patients were re-evaluated 3 weeks after antibacterial therapy with PSA (free/total) and urinalysis. Ten core biopsies were taken with transrectal ultrasound. No differences were found in terms of age, pre- and post-treatment PSA, and PSA varying between patients with and without inflammation in the prostatic massage. In 18 patients, PSA decreased below 4 ng/ml. Prostate cancer was found in 10.8% of the patients with PSA between 4 and 10 ng/ml and none of the patients with PSA values below 4 ng/ml. We suggest an antibiotic therapy for 3 weeks without regarding inflammation findings when PSA is in the gray zone, for biopsy decision.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16718277     DOI: 10.1038/sj.pcan.4500885

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  7 in total

1.  Do antibiotics decrease prostate-specific antigen levels and reduce the need for prostate biopsy in type IV prostatitis? A systematic literature review.

Authors:  Karel T Buddingh; Marlies G F Maatje; Hein Putter; René F Kropman; Rob C M Pelger
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

2.  Endorectal multiparametric 3-tesla magnetic resonance imaging associated with systematic cognitive biopsies does not increase prostate cancer detection rate: a randomized prospective trial.

Authors:  Gianluigi Taverna; Giorgio Bozzini; Fabio Grizzi; Mauro Seveso; Alberto Mandressi; Luca Balzarini; Federica Mrakic; Pietro Bono; Oliviero De Franceco; NicolòMaria Buffi; Giovanni Lughezzani; Massimo Lazzeri; Paolo Casale; Giorgio Ferruccio Guazzoni
Journal:  World J Urol       Date:  2015-10-19       Impact factor: 4.226

3.  The role of empiric antibiotic treatment in preventing unnecessary prostate biopsies in asymptomatic patients with PSA levels between 4 and 10 ng/ml.

Authors:  Ali Saribacak; Hasan Yilmaz; Seyfettin Ciftci; Murat Ustuner; Levend Ozkan; Tayyar Alp Ozkan; Ozdal Dillioglugil
Journal:  Int J Clin Exp Med       Date:  2014-08-15

4.  The effect of antibiotherapy on prostate-specific antigen levels and prostate biopsy results in patients with levels 2.5 to 10 ng/mL.

Authors:  Gokhan Toktas; Murat Demiray; Erkan Erkan; Ramazan Kocaaslan; Ugur Yucetas; Suleyman Erdinc Unluer
Journal:  J Endourol       Date:  2013-08       Impact factor: 2.942

5.  Does PSA reduction after antibiotic therapy permits postpone prostate biopsy in asymptomatic men with PSA levels between 4 and 10 ng/mL?

Authors:  W F S Busato; G L Almeida; Jamylle Geraldo; F S Busato
Journal:  Int Braz J Urol       Date:  2015 Mar-Apr       Impact factor: 1.541

6.  The Relationship Between Prostate Biopsy Results and PSA and Free PSA Ratio Changes in Elevated Serum PSA Patients with and without Antibiotherapy.

Authors:  Mesut Berkan Duran; Ayhan Dirim; Hakan Ozkardes
Journal:  Asian Pac J Cancer Prev       Date:  2020-04-01

Review 7.  Antibiotic therapy in patients with high prostate-specific antigen: Is it worth considering? A systematic review.

Authors:  Diaa-Eldin Taha; Omar M Aboumarzouk; Islam Osama Koraiem; Ahmed A Shokeir
Journal:  Arab J Urol       Date:  2019-10-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.